173 related articles for article (PubMed ID: 16278585)
1. Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin.
Kirk AD; Mannon RB; Kleiner DE; Swanson JS; Kampen RL; Cendales LK; Elster EA; Wakefield T; Chamberlain C; Hoffmann SC; Hale DA
Transplantation; 2005 Oct; 80(8):1051-9. PubMed ID: 16278585
[TBL] [Abstract][Full Text] [Related]
2. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).
Kirk AD; Hale DA; Mannon RB; Kleiner DE; Hoffmann SC; Kampen RL; Cendales LK; Tadaki DK; Harlan DM; Swanson SJ
Transplantation; 2003 Jul; 76(1):120-9. PubMed ID: 12865797
[TBL] [Abstract][Full Text] [Related]
3. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin.
Thomas JM; Contreras JL; Jiang XL; Eckhoff DE; Wang PX; Hubbard WJ; Lobashevsky AL; Wang W; Asiedu C; Stavrou S; Cook WJ; Robbin ML; Thomas FT; Neville DM
Transplantation; 1999 Dec; 68(11):1660-73. PubMed ID: 10609942
[TBL] [Abstract][Full Text] [Related]
4. IL-10 and IL-4 in skin allograft survival induced by T-cell depletion plus deoxyspergualin.
Asiedu C; Andrades P; Ray PD; George JF; Thomas JM
Cell Transplant; 2008; 17(6):713-20. PubMed ID: 18819259
[TBL] [Abstract][Full Text] [Related]
5. Th17 cells in alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy.
Hester J; Mills N; Shankar S; Carvalho-Gaspar M; Friend P; Wood KJ
Transplantation; 2011 Apr; 91(7):744-50. PubMed ID: 21412187
[TBL] [Abstract][Full Text] [Related]
6. T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients.
Bloom DD; Hu H; Fechner JH; Knechtle SJ
Transplantation; 2006 Jan; 81(1):81-7. PubMed ID: 16421481
[TBL] [Abstract][Full Text] [Related]
7. Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.
Hancock WW; Miyatake T; Koyamada N; Kut JP; Soares M; Russell ME; Bach FH; Sayegh MH
Transplantation; 1997 Sep; 64(5):696-704. PubMed ID: 9311705
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H).
Gallon L; Gagliardini E; Benigni A; Kaufman D; Waheed A; Noris M; Remuzzi G
Clin J Am Soc Nephrol; 2006 May; 1(3):539-45. PubMed ID: 17699257
[TBL] [Abstract][Full Text] [Related]
9. Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.
Pascual J; Pirsch JD; Odorico JS; Torrealba JR; Djamali A; Becker YT; Voss B; Leverson GE; Knechtle SJ; Sollinger HW; Samaniego-Picota MD
Transplantation; 2009 Jan; 87(1):125-32. PubMed ID: 19136902
[TBL] [Abstract][Full Text] [Related]
10. Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression.
Trzonkowski P; Zilvetti M; Chapman S; Wieckiewicz J; Sutherland A; Friend P; Wood KJ
Am J Transplant; 2008 Feb; 8(2):338-47. PubMed ID: 18211507
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction.
Weissenbacher A; Hautz T; Kimelman M; Oberhuber R; Ulmer H; Bösmüller C; Maglione M; Schneeberger S
J Immunol Res; 2015; 2015():985460. PubMed ID: 26171403
[TBL] [Abstract][Full Text] [Related]
12. The free radical scavenger S-PBN significantly prolongs DSG-mediated graft survival in experimental xenotransplantation.
Biglarnia AR; Emanuelsson C; Quach M; Clausen F; Larsson E; Schneider MK; Tufveson G; Lorant T
Xenotransplantation; 2012; 19(3):166-76. PubMed ID: 22702468
[TBL] [Abstract][Full Text] [Related]
13. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.
Pearl JP; Parris J; Hale DA; Hoffmann SC; Bernstein WB; McCoy KL; Swanson SJ; Mannon RB; Roederer M; Kirk AD
Am J Transplant; 2005 Mar; 5(3):465-74. PubMed ID: 15707400
[TBL] [Abstract][Full Text] [Related]
14. Treatment with immunotoxin.
Knechtle SJ
Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):681-9. PubMed ID: 11375071
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of Alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation.
Vathsala A; Ona ET; Tan SY; Suresh S; Lou HX; Casasola CB; Wong HC; Machin D; Chiang GS; Danguilan RA; Calne R
Transplantation; 2005 Sep; 80(6):765-74. PubMed ID: 16210963
[TBL] [Abstract][Full Text] [Related]
16. Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control.
Contreras JL; Wang PX; Eckhoff DE; Lobashevsky AL; Asiedu C; Frenette L; Robbin ML; Hubbard WJ; Cartner S; Nadler S; Cook WJ; Sharff J; Shiloach J; Thomas FT; Neville DM; Thomas JM
Transplantation; 1998 May; 65(9):1159-69. PubMed ID: 9603161
[TBL] [Abstract][Full Text] [Related]
17. Differential promotion of hematopoietic chimerism and inhibition of alloreactive T cell proliferation by combinations of anti-CD40Ligand, anti-LFA-1, everolimus, and deoxyspergualin.
Metzler B; Gfeller P; Wieczorek G; Katopodis A
Transpl Immunol; 2008 Nov; 20(1-2):106-12. PubMed ID: 18675355
[TBL] [Abstract][Full Text] [Related]
18. C4d positivity is often associated with acute cellular rejection in renal transplant biopsies following Campath-1H (Alemtuzumab) induction.
Zhang PL; Malek SK; Blasick TM; Pennington JR; Masker KK; Lun M; Potdar S
Ann Clin Lab Sci; 2007; 37(2):121-6. PubMed ID: 17522366
[TBL] [Abstract][Full Text] [Related]
19. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü TM; Yang SL; Wu WZ; Tan JM
Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
[TBL] [Abstract][Full Text] [Related]
20. Treatment of simultaneous acute antibody-mediated rejection and acute cellular rejection with alemtuzumab in kidney transplantation: a case report.
Jirasiritham S; Khunprakant R; Techawathanawanna N; Jirasiritham S; Mavichak V
Transplant Proc; 2010 Apr; 42(3):987-9. PubMed ID: 20430222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
